Venous thromboembolism (in bladder cancer patients) research hub

Thromboprophylaxis with apixaban during neoadjuvant therapy for muscle-invasive bladder cancer (ACB): An international randomized controlled trial evaluating apixaban versus no anticoagulation in patients scheduled to undergo radical cystectomy or chemoradiotherapy for muscle-invasive bladder cancer

This clinical study looks at whether taking a blood-thinning tablet called apixaban can help prevent blood clots in people receiving treatment for bladder cancer before surgery or radiotherapy. Researchers want to see if this medicine safely stops blood clots forming without causing unwanted bleeding.